#NAFLD

A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Vitamin B-12 and folate not only lowered homocysteine levels in the blood but also improved liver inflammation in mice.

Researchers suggest that 67.3 million people are living with NAFLD in the United States and Canada.

The incidence rate is expected to be especially high among young women with alcoholic liver disease.

If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.

Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.

Twelve states have an adult obesity prevalence of 35% or more.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.

As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.

NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.

Obesity increased the risk of liver disease to a smaller extent, according to a meta-analysis study.

Researchers found that overconsumption of fructose overburdened the small intestine, leading to fatty liver disease.

While women have a lower risk for NAFLD, once present, the disease advanced more rapidly.

This connection may be attributable to lower iron levels.

A new study analyzed how non-alcoholic fatty liver disease affects maternal health outcomes.

Non-alcoholic fatty liver disease can be driven by toxin exposure.